116 related articles for article (PubMed ID: 1793478)
1. Synthesis and nootropic activity of 2-oxo-1-pyrrolidinesulfonic acid derivatives.
Cerri A; Farina C; Pinza M; Banfi S
Farmaco; 1991; 46(7-8):959-66. PubMed ID: 1793478
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and amnesia-reversal activity of a series of 7- and 5-membered 3-acylamino lactams.
Angelucci L; Calvisi P; Catini R; Cosentino U; Cozzolino R; De Witt P; Ghirardi O; Giannessi F; Giuliani A; Guaraldi D
J Med Chem; 1993 May; 36(11):1511-9. PubMed ID: 8496921
[TBL] [Abstract][Full Text] [Related]
3. Effects of oxiracetam on learning and memory in animals: comparison with piracetam.
Mondadori C; Classen W; Borkowski J; Ducret T; Buerki H; Schadé A
Clin Neuropharmacol; 1986; 9 Suppl 3():S27-38. PubMed ID: 3594453
[TBL] [Abstract][Full Text] [Related]
4. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats.
Sakurai T; Ojima H; Yamasaki T; Kojima H; Akashi A
Jpn J Pharmacol; 1989 May; 50(1):47-53. PubMed ID: 2724699
[TBL] [Abstract][Full Text] [Related]
5. Interaction between nootropic drugs and methamphetamine on avoidance acquisition but not on locomotor activity in mice.
Sansone M; Ammassari-Teule M; Oliverio A
Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):229-35. PubMed ID: 4096612
[TBL] [Abstract][Full Text] [Related]
6. Oxiracetam prevents mecamylamine-induced impairment of active, but not passive, avoidance learning in mice.
Sansone M; Castellano C; Battaglia M; Ammassari-Teule M
Pharmacol Biochem Behav; 1990 Jun; 36(2):389-92. PubMed ID: 2356212
[TBL] [Abstract][Full Text] [Related]
7. The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters.
Mondadori C; Ducret T; Borkowski J
Behav Brain Res; 1989 May; 33(1):79-82. PubMed ID: 2736062
[TBL] [Abstract][Full Text] [Related]
8. Avoidance facilitation by nootropics.
Sansone M; Oliverio A
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13 Suppl():S89-97. PubMed ID: 2616794
[TBL] [Abstract][Full Text] [Related]
9. [Comparative influence of nootropic preparations on the emetic effect of morphine].
Naumova VI; Krylova IN; Drozd IuV; Polev PV; Bashnin IuI
Biull Eksp Biol Med; 1989 Jun; 107(6):711-3. PubMed ID: 2790169
[TBL] [Abstract][Full Text] [Related]
10. [The synthesis of new pyrrolidone derivatives with psychotropic action].
Stefănescu E; Petrovanu M; Ciocoiu I; Caproşu M; Bîcu E
Rev Med Chir Soc Med Nat Iasi; 1992; 96(3-4):241-2. PubMed ID: 1344862
[TBL] [Abstract][Full Text] [Related]
11. Potential nootropic agents, 4-alkoxy-2-(1-piperazinyl)quinazoline derivatives.
Hori M; Iemura R; Hara H; Sukamoto T; Ito K; Ohtaka H
Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):367-71. PubMed ID: 2054860
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptic muscarinic antagonist secoverine in mice.
Ammassari-Teule M; Castellano C; Sansone M
Behav Brain Res; 1992 Mar; 47(1):93-5. PubMed ID: 1571105
[TBL] [Abstract][Full Text] [Related]
13. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
Spignoli G; Pepeu G
Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
[TBL] [Abstract][Full Text] [Related]
14. Search for substances with antioxidant and antiamnestic activities among 2-substituted 4-(3H)-quinazolones.
Kovalenko S; Belenichev I; Nikitin V; Karpenko A
Acta Pol Pharm; 2003; 60(4):275-9. PubMed ID: 14714855
[TBL] [Abstract][Full Text] [Related]
15. Oxiracetam prevents haloperidol-induced passive avoidance impairment in mice.
Castellano C; Battaglia M; Sansone M
Pharmacol Biochem Behav; 1992 Aug; 42(4):797-801. PubMed ID: 1513861
[TBL] [Abstract][Full Text] [Related]
16. Effects of oxiracetam, physostigmine, and their combination on active and passive avoidance learning in mice.
Sansone M; Castellano C; Palazzesi S; Battaglia M; Ammassari-Teule M
Pharmacol Biochem Behav; 1993 Feb; 44(2):451-5. PubMed ID: 8446678
[TBL] [Abstract][Full Text] [Related]
17. [Participation of dihydropyridine-sensitive calcium channels in psychotropic effects of nootropic drugs].
Bobkov IuG; Polev PV; Machula AI; Val'dman EA; Soldatov NM; Dudkin SM
Biull Eksp Biol Med; 1990 Oct; 110(10):386-9. PubMed ID: 2177669
[TBL] [Abstract][Full Text] [Related]
18. Influence of nootropic drugs on the memory-impairing effect of diethyldithiocarbamate and clonidine in "step down" passive avoidance in albino rats.
Genkova-Papasova M; Lazarova-Bakurova M
Acta Physiol Pharmacol Bulg; 1988; 14(4):36-41. PubMed ID: 2854355
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study of the nootropic properties of piracetam and oxiracetam].
Krylova IN; Antonova LV; Kamenskiĭ AA; Iasnetsov VV
Farmakol Toksikol; 1991; 54(1):14-6. PubMed ID: 1860490
[TBL] [Abstract][Full Text] [Related]
20. Memory effects of a group of newly-synthesized pyrrolidine derivatives with putative nootropic effect.
Petkov VD; Lazarova MB; Belcheva S; Getova D; Petkova B; Petkov VV; Stancheva S; Alova L; Konstantinova E; Todorov I
Acta Physiol Pharmacol Bulg; 1991; 17(2-3):61-74. PubMed ID: 1819919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
